Palantir (PLTR) 10-Q 8 Aug 22 2022 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jun. 30, 2022	Aug. 01, 2022
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2022
Document Transition Report	false
Entity File Number	001-39540
Entity Registrant Name	Palantir Technologies Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	68-0551851
Entity Address, Address Line One	1555 Blake Street, Suite 250
Entity Address, City or Town	Denver
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80202
City Area Code	(720)
Local Phone Number	358-3679
Title of 12(b) Security	Class A Common Stock, par value $0.001 per share
Trading Symbol	PLTR
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001321655
Amendment Flag	false
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		1,963,814,949
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		99,342,246
Class F Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		1,005,000

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 2,358,393	$ 2,290,674
Restricted cash	28,125	36,628
Accounts receivable, net	265,826	190,923
Marketable securities	99,210	234,153
Prepaid expenses and other current assets	150,885	110,872
Total current assets	2,902,439	2,863,250
Property and equipment, net	47,644	31,304
Restricted cash, noncurrent	28,647	39,612
Operating lease right-of-use assets	211,410	216,898
Other assets	92,198	96,386
Total assets	3,282,338	3,247,450
Current liabilities:
Accounts payable	56,798	74,907
Accrued liabilities	187,568	155,806
Deferred revenue	219,441	227,816
Customer deposits	161,026	161,605
Operating lease liabilities	40,909	39,927
Total current liabilities	665,742	660,061
Deferred revenue, noncurrent	34,143	40,217
Customer deposits, noncurrent	15,412	33,699
Operating lease liabilities, noncurrent	216,059	220,146
Other noncurrent liabilities	2,158	2,297
Total liabilities	933,514	956,420
Commitments and Contingencies (Note 7)
Stockholders’ equity:
Common stock, $0.001 par value: 20,000,000 Class A shares authorized as of June 30, 2022 and December 31, 2021; 1,962,382 and 1,926,589 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively; 2,700,000 Class B shares authorized as of June 30, 2022 and December 31, 2021; 99,354 and 99,880 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively; and 1,005 Class F shares authorized, issued, and outstanding as of June 30, 2022 and December 31, 2021	2,063	2,027
Additional paid-in capital	8,119,876	7,777,085
Accumulated other comprehensive loss	(6,674)	(2,349)
Accumulated deficit	(5,766,441)	(5,485,733)
Total stockholders’ equity	2,348,824	2,291,030
Total liabilities and stockholders’ equity	$ 3,282,338	$ 3,247,450

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2022	Dec. 31, 2021
Common stock, shares authorized	22,701,005,000	22,701,005,000
Common stock, shares issued	2,062,741,000	2,027,474,000
Common stock, shares outstanding	2,062,741,000	2,027,474,000
Class A Common Stock
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	20,000,000,000	20,000,000,000
Common stock, shares issued	1,962,382,000	1,926,589,000
Common stock, shares outstanding	1,962,382,000	1,926,589,000
Class B Common Stock
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	2,700,000,000	2,700,000,000
Common stock, shares issued	99,354,000	99,880,000
Common stock, shares outstanding	99,354,000	99,880,000
Class F Common Stock
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	1,005,000	1,005,000
Common stock, shares issued	1,005,000	1,005,000
Common stock, shares outstanding	1,005,000	1,005,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Revenue	$ 473,010	$ 375,642	$ 919,367	$ 716,876
Cost of revenue	102,224	90,926	196,627	165,037
Gross profit	370,786	284,716	722,740	551,839
Operating expenses:
Sales and marketing	168,875	162,379	329,360	298,476
Research and development	88,171	110,524	176,772	208,995
General and administrative	155,485	157,961	297,792	304,530
Total operating expenses	412,531	430,864	803,924	812,001
Loss from operations	(41,745)	(146,148)	(81,184)	(260,162)
Interest income	1,472	372	2,019	748
Interest expense	(670)	(590)	(1,264)	(2,430)
Other income (expense), net	(135,798)	2,125	(195,668)	(2,769)
Loss before provision for (benefit from) income taxes	(176,741)	(144,241)	(276,097)	(264,613)
Provision for (benefit from) income taxes	2,588	(5,661)	4,611	(2,559)
Net loss	$ (179,329)	$ (138,580)	$ (280,708)	$ (262,054)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.09)	$ (0.07)	$ (0.14)	$ (0.14)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.09)	$ (0.07)	$ (0.14)	$ (0.14)
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, basic (in shares)	2,054,799,000	1,894,606,000	2,045,604,000	1,858,085,000
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, diluted (in shares)	2,054,799,000	1,894,606,000	2,045,604,000	1,858,085,000

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (179,329)	$ (138,580)	$ (280,708)	$ (262,054)
Other comprehensive income (loss)
Foreign currency translation adjustments	(2,630)	(800)	(4,325)	2,810
Comprehensive loss	$ (181,959)	$ (139,380)	$ (285,033)	$ (259,244)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Balance at the beginning of period (in shares) at Dec. 31, 2020		1,792,140,000
Balance at beginning of period at Dec. 31, 2020	$ 1,522,550	$ 1,792	$ 6,488,857	$ (2,745)	$ (4,965,354)
Issuance of common stock from the exercise of stock options (in shares)		114,471,000
Issuance of common stock from the exercise of stock options	376,688	$ 114	376,574
Issuance of common stock upon vesting of RSUs (in shares)		23,832,000
Issuance of common stock upon vesting of RSUs	0	$ 24	(24)
Issuance of common stock upon vesting of growth units (in shares)		1,471,000
Issuance of common stock upon vesting of growth units	0	$ 1	(1)
Issuance of common stock upon net exercise of common stock warrants (in shares)		4,664,000
Issuance of common stock upon net exercise of common stock warrants and other	1,712	$ 6	1,706
Stock-based compensation	427,257		427,257
Other comprehensive loss	2,810			2,810
Net loss	(262,054)				(262,054)
Balance at end of period (in shares) at Jun. 30, 2021		1,936,578,000
Balance at end of period at Jun. 30, 2021	2,068,963	$ 1,937	7,294,369	65	(5,227,408)
Balance at the beginning of period (in shares) at Mar. 31, 2021		1,860,607,000
Balance at beginning of period at Mar. 31, 2021	1,805,943	$ 1,860	6,892,046	865	(5,088,828)
Issuance of common stock from the exercise of stock options (in shares)		59,171,000
Issuance of common stock from the exercise of stock options	167,828	$ 59	167,769
Issuance of common stock upon vesting of RSUs (in shares)		12,872,000
Issuance of common stock upon vesting of RSUs	0	$ 13	(13)
Issuance of common stock upon net exercise of common stock warrants (in shares)		3,928,000
Issuance of common stock upon net exercise of common stock warrants and other	1,712	$ 5	1,707
Stock-based compensation	232,860		232,860
Other comprehensive loss	(800)			(800)
Net loss	(138,580)				(138,580)
Balance at end of period (in shares) at Jun. 30, 2021		1,936,578,000
Balance at end of period at Jun. 30, 2021	$ 2,068,963	$ 1,937	7,294,369	65	(5,227,408)
Balance at the beginning of period (in shares) at Dec. 31, 2021	2,027,474,000	2,027,474,000
Balance at beginning of period at Dec. 31, 2021	$ 2,291,030	$ 2,027	7,777,085	(2,349)	(5,485,733)
Issuance of common stock from the exercise of stock options (in shares)	11,434,000	11,434,000
Issuance of common stock from the exercise of stock options	$ 47,541	$ 12	47,529
Issuance of common stock upon vesting of RSUs (in shares)		23,833,000
Issuance of common stock upon vesting of RSUs	0	$ 24	(24)
Stock-based compensation	295,286		295,286
Other comprehensive loss	(4,325)			(4,325)
Net loss	$ (280,708)				(280,708)
Balance at end of period (in shares) at Jun. 30, 2022	2,062,741,000	2,062,741,000
Balance at end of period at Jun. 30, 2022	$ 2,348,824	$ 2,063	8,119,876	(6,674)	(5,766,441)
Balance at the beginning of period (in shares) at Mar. 31, 2022		2,045,876,000
Balance at beginning of period at Mar. 31, 2022	2,364,746	$ 2,046	7,953,856	(4,044)	(5,587,112)
Issuance of common stock from the exercise of stock options (in shares)		4,780,000
Issuance of common stock from the exercise of stock options	20,316	$ 5	20,311
Issuance of common stock upon vesting of RSUs (in shares)		12,085,000
Issuance of common stock upon vesting of RSUs	0	$ 12	(12)
Stock-based compensation	145,721		145,721
Other comprehensive loss	(2,630)			(2,630)
Net loss	$ (179,329)				(179,329)
Balance at end of period (in shares) at Jun. 30, 2022	2,062,741,000	2,062,741,000
Balance at end of period at Jun. 30, 2022	$ 2,348,824	$ 2,063	$ 8,119,876	$ (6,674)	$ (5,766,441)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Operating activities
Net loss	$ (280,708)	$ (262,054)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	9,207	7,999
Stock-based compensation	295,092	426,473
Deferred income taxes	(14)	(2,162)
Non-cash operating lease expense	20,246	14,435
Unrealized and realized (gain) loss from marketable securities, net	201,341	0
Other operating activities	(3,678)	560
Changes in operating assets and liabilities:
Accounts receivable	(75,739)	(83,883)
Prepaid expenses and other current assets	(36,351)	12,770
Other assets	8,087	(7,360)
Accounts payable	(19,985)	14,589
Accrued liabilities	28,850	9,070
Deferred revenue, current and noncurrent	(11,681)	(3,679)
Customer deposits, current and noncurrent	(19,314)	28,668
Operating lease liabilities, current and noncurrent	(17,331)	(15,795)
Other noncurrent liabilities	(114)	0
Net cash provided by operating activities	97,908	139,631
Investing activities
Purchases of property and equipment	(20,673)	(1,405)
Purchases of marketable securities	(89,500)	0
Proceeds from sales of marketable securities	19,009	0
Net cash used in investing activities	(91,164)	(1,405)
Financing activities
Principal payments on borrowings	0	(200,000)
Proceeds from the exercise of common stock options	47,541	376,688
Other financing activities	307	(1,744)
Net cash provided by financing activities	47,848	174,944
Effect of foreign exchange on cash, cash equivalents, and restricted cash	(6,341)	(1,496)
Net increase in cash, cash equivalents, and restricted cash	48,251	311,674
Cash, cash equivalents, and restricted cash - beginning of period	2,366,914	2,128,146
Cash, cash equivalents, and restricted cash - end of period	2,415,165	2,439,820
Supplemental disclosures of cash flow information
Cash paid for income taxes	1,374	3,425
Cash paid for interest	$ 5	$ 2,381

Organization

Organization	6 Months Ended
	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	OrganizationPalantir Technologies Inc. (including its subsidiaries, “Palantir” or the “Company”) was incorporated in Delaware on May 6, 2003. The Company builds and deploys software platforms that serve as the central operating systems for its customers.

Significant Accounting Policies

Significant Accounting Policies	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies Basis of Presentation and Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The accompanying condensed consolidated financial statements include the accounts of Palantir Technologies Inc. and its consolidated subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Investments in entities where the Company holds at least a 20% ownership interest and has the ability to exercise significant influence over the investee, but does not control, are accounted for using the equity method of accounting. Certain prior year balances have been reclassified to conform to the current year presentation. Such reclassifications did not affect total revenues, loss from operations, net loss, or cash flows. The Company's fiscal year ends on December 31. The unaudited condensed consolidated balance sheet as of December 31, 2021 included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including certain notes required by GAAP on an annual reporting basis. In management’s opinion, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the balance sheets and statements of operations, comprehensive loss, stockholders’ equity, and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year or any future period. These unaudited condensed consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements and notes included in its Annual Report on Form 10-K for the year ended December 31, 2021, which was filed with the SEC on February 24, 2022. Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include, but are not limited to, the identification of performance obligations in customer contracts; the valuation of deferred tax assets and uncertain tax positions; the collectability of contract consideration, including accounts receivable; the useful lives of tangible assets; and the incremental borrowing rate for operating leases. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect the Company’s financial position and results of operations. Summary of Significant Accounting Policies The Company’s significant accounting policies are discussed in Note 2. Significant Accounting Policies in the notes to consolidated financial statements in its Annual Report on Form 10-K for the year ended December 31, 2021, which was filed with the SEC on February 24, 2022. There have been no significant changes to these policies during the six months ended June 30, 2022. Cash, Cash Equivalents, and Restricted Cash The Company considers all highly liquid investments purchased with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents primarily consist of amounts invested in money market funds. Restricted cash primarily consists of cash and certificates of deposit that are held as collateral against letters of credit and guarantees that the Company is required to maintain for operating lease agreements, certain customer contracts, and other guarantees and financing arrangements. The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the amounts shown in the condensed consolidated statements of cash flows (in thousands): As of June 30, 2022 2021 Cash and cash equivalents $ 2,358,393 $ 2,341,156 Restricted cash 28,125 36,750 Restricted cash, noncurrent 28,647 61,914 Total cash, cash equivalents, and restricted cash $ 2,415,165 $ 2,439,820 Accounts Receivable and Allowance for Credit Losses Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses, if any. The Company generally grants non-collateralized credit terms to its customers. Allowance for credit losses is based on the Company’s best estimate of probable losses inherent in its accounts receivable portfolio and is determined based on expectations of the customer’s ability to pay by considering factors such as customer type (commercial or government), historical experience, financial position of the customer, age of the accounts receivable, current economic conditions, including the ongoing COVID-19 pandemic, and reasonable and supportable forward-looking factors about its portfolio and future economic conditions. Accounts receivable are written-off and charged against an allowance for credit losses when the Company has exhausted collection efforts without success. Based upon the Company’s assessment as of June 30, 2022 and December 31, 2021, the allowances for credit losses were not material. Concentrations of Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, accounts receivable, and marketable securities. Cash equivalents primarily consist of money market funds with original maturities of three months or less, which are invested primarily with U.S. financial institutions. Cash deposits with financial institutions, including restricted cash, generally exceed federally insured limits. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts. The Company is exposed to concentrations of credit risk with respect to accounts receivable presented on the condensed consolidated balance sheets. The Company’s accounts receivable balances as of June 30, 2022 and December 31, 2021 were $265.8 million and $190.9 million, respectively. No single customer represented more than 10% of total accounts receivable as of June 30, 2022 or December 31, 2021.

Contract Liabilities and Remain

Contract Liabilities and Remaining Performance Obligations	6 Months Ended
	Jun. 30, 2022
Revenue from Contract with Customer [Abstract]
Contract Liabilities and Remaining Performance Obligations	Contract Liabilities and Remaining Performance Obligations Contract Liabilities The Company’s contract liabilities consist of deferred revenue and customer deposits. As of June 30, 2022 and December 31, 2021, the Company's contract liability balances were $430.0 million and $463.3 million, respectively. Revenue of $299.2 million and $285.4 million was recognized during the six months ended June 30, 2022 and 2021, respectively, that was included in the contract liability balances as of December 31, 2021 and 2020, respectively. Remaining Performance Obligations The Company’s arrangements with its customers often have terms that span over multiple years. However, the Company allows many of its customers to terminate contracts for convenience prior to the end of the stated term with less than twelve months’ notice. Revenue allocated to remaining performance obligations represents noncancelable contracted revenue that has not yet been recognized, which includes deferred revenue and, in certain instances, amounts that will be invoiced. The Company has elected the practical expedient allowing the Company to not disclose remaining performance obligations for contracts with original terms of twelve months or less. Cancelable contracted revenue, which includes customer deposits, is not considered a remaining performance obligation. The Company’s remaining performance obligations were $1.2 billion as of June 30, 2022, of which the Company expects to recognize approximately 44% as revenue over the next 12 months, 43% as revenue over the subsequent 13 to 36 months, and the remainder thereafter. Disaggregation of Revenue See Note 12. Segment and Geographic Information for disaggregated revenue by customer segment and geographic region.

Investments and Fair Value Meas

Investments and Fair Value Measurements	6 Months Ended
	Jun. 30, 2022
Fair Value Disclosures [Abstract]
Investments and Fair Value Measurements	Investments and Fair Value Measurements The following tables present the Company’s assets that are measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation (in thousands): As of June 30, 2022 Total Level 1 Level 2 Level 3 Assets: Cash and cash equivalents: Money market funds $ 385,721 $ 385,721 $ — $ — Certificates of deposit 9,358 — 9,358 — Restricted cash, current and noncurrent Certificates of deposit 32,292 — 32,292 — Marketable securities: Marketable securities 99,210 99,210 — — Total $ 526,581 $ 484,931 $ 41,650 $ — As of December 31, 2021 Total Level 1 Level 2 Level 3 Assets: Cash and cash equivalents: Money market funds $ 507,317 $ 507,317 $ — $ — Certificates of deposit 6,844 — 6,844 — Restricted cash, current and noncurrent Certificates of deposit 45,048 — 45,048 — Marketable securities: Marketable securities 234,153 234,153 — — Total $ 793,362 $ 741,470 $ 51,892 $ — Certificates of Deposit The Company’s Level 2 instruments consist of restricted cash invested in certificates of deposit. The fair value of such instruments is estimated based on valuations obtained from third-party pricing services that utilize industry standard valuation models, including both income-based and market-based approaches, for which all significant inputs are observable either directly or indirectly. These inputs include interest rate curves, foreign exchange rates, and credit ratings. Marketable Securities Marketable securities consist of equity securities in publicly-traded companies and are recorded at fair market value each reporting period. Realized and unrealized gains and losses are recorded in other income (expense), net on the condensed consolidated statements of operations. During the three and six months ended June 30, 2022, the Company recorded net unrealized losses of $122.8 million and $174.7 million, respectively, and realized losses of $15.7 million and $26.6 million, respectively, within other income (expense), net on the condensed consolidated statements of operations. Investments Since 2021, the Company has approved and entered into certain agreements (“Investment Agreements”) to purchase, or commit to purchase, as further discussed in Note 7. Commitments and Contingencies — Investment Commitments , shares of various entities, including special purpose acquisition companies and/or other privately-held or publicly-traded entities (each, an “Investee,” and such purchases, and commitments to purchase, the “Investments”). In connection with signing the Investment Agreements, each Investee or an associated entity and the Company entered into a commercial contract for access to the Company’s products and services. The total value of such commercial contracts was $754.9 million as of June 30, 2022, which is inclusive of $116.2 million of contractual options. The terms of such contracts, including contractual options, range from three The Company assesses the concurrent agreements under the non-monetary guidance within ASC 606— Revenue from Contracts with Customers as well as the commercial substance of each arrangement considering the customer’s ability and intention to pay as well as the Company’s obligation to perform under each contract. The total revenue recognized from these commercial contracts during the three and six months ended June 30, 2022 was $31.4 million and $70.6 million, respectively. During the six months ended June 30, 2022 and the year ended December 31, 2021, the Company purchased shares for a total investment of $89.5 million and $326.0 million, respectively. No investments were purchased under such Investment Agreements during the three months ended June 30, 2022. Alternative Investments During the year ended December 31, 2021, the Company purchased $50.9 million in 100-ounce gold bars. The gold bars are kept in a secure third-party facility located in the northeastern United States. The Company is able to take physical possession of the gold bars stored at the facility at any time with reasonable notice.

Balance Sheet Components

Balance Sheet Components	6 Months Ended
	Jun. 30, 2022
Balance Sheet Related Disclosures [Abstract]
Balance Sheet Components	Balance Sheet Components Property and Equipment, Net Property and equipment, net consisted of the following (in thousands): As of June 30, As of December 31, 2021 Leasehold improvements $ 71,834 $ 72,834 Computer equipment, software, and other 29,467 16,916 Furniture and fixtures 10,137 8,358 Construction in progress 7,591 3,126 Total property and equipment, gross 119,029 101,234 Less: accumulated depreciation and amortization (71,385) (69,930) Total property and equipment, net $ 47,644 $ 31,304 Depreciation and amortization expense related to property and equipment, net was $4.5 million and $3.1 million for the three months ended June 30, 2022 and 2021, respectively, and $8.4 million and $6.3 million for the six months ended June 30, 2022 and 2021, respectively. Accrued Liabilities Accrued liabilities consisted of the following (in thousands): As of June 30, As of December 31, 2021 Accrued payroll and related expenses $ 47,046 $ 60,732 Accrued legal 42,912 13,086 Accrued other liabilities 97,610 81,988 Total accrued liabilities $ 187,568 $ 155,806

Debt

Debt	6 Months Ended
	Jun. 30, 2022
Debt Disclosure [Abstract]
Debt	Debt 2014 Credit Facility In October 2014, the Company entered into an unsecured revolving credit facility, which has been subsequently secured by substantially all of the Company’s assets and amended from time to time (as amended, the “2014 Credit Facility”), including on March 31, 2022 (the “March 2022 Amendment”). The March 2022 Amendment provides for, among other things, an extension of the revolving loan facility maturity date to March 31, 2027 and an increase of $100.0 million to the lenders’ revolving commitments for total revolving commitments of $500.0 million. The 2014 Credit Facility allows for the drawdown of up to $500.0 million to fund working capital and general corporate expenditures. Outstanding balances under the 2014 Credit Facility would incur interest at the Secured Overnight Financing Rate (“SOFR”) as administered by the Federal Reserve Bank of New York, or a successor administrator of the SOFR (or the applicable benchmark replacement), plus 2.00% or a base rate plus 1.00%, subject to certain adjustments. The Company incurs a commitment fee of 0.30% assessed on the daily average undrawn portion of revolving commitments. Applicable interest and commitment fees are payable quarterly or more or less frequently in certain circumstances. The 2014 Credit Facility also allows for an incremental loan facility of additional term loans or revolving loans in an aggregate principal amount up to the amount and upon the terms and conditions set forth therein with one or more existing or new lenders upon mutual agreement between the Company and such lenders. The 2014 Credit Facility was subsequently amended in July 2022. See Note 13. Subsequent Events for additional information. As of June 30, 2022, the Company had no outstanding debt balances and $500.0 million undrawn revolving commitments under the 2014 Credit Facility. The 2014 Credit Facility contains customary representations and warranties, and certain financial and nonfinancial covenants, including but not limited to maintaining minimum liquidity of $50.0 million, and certain limitations on liens and indebtedness. The Company was in compliance with all covenants associated with the 2014 Credit Facility as of June 30, 2022.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Purchase Commitments In December 2019, the Company entered into, and subsequently amended, a minimum annual commitment to purchase cloud hosting services of at least $1.49 billion over six three Investment Commitments The Company approved and entered into certain Investment Agreements with Investees, as further discussed in Note 4. Investments and Fair Value Measurements — Investments . As of June 30, 2022, the Company had an outstanding investment commitment relating to the planned merger of Rubicon Technologies, LLC (“Rubicon”) with Founder SPAC, effective as of December 15, 2021, subject to the applicable terms and conditions, to purchase a total of 3.5 million shares for an aggregate purchase price of $35.0 million. The closing of such investment commitment is contingent upon the completion of a proposed business combination by and among Rubicon and other applicable parties. The Company’s commercial contract with Rubicon contains termination for convenience clauses in the event the proposed business combination or the Company’s proposed investment is not completed. Litigation and Legal Proceedings From time to time, third parties may assert patent infringement claims against the Company. In addition, from time to time, the Company may be subject to other legal proceedings and claims in the ordinary course of business, including claims of alleged infringement of trademarks, copyrights, and other intellectual property rights; employment claims; securities claims; investor claims; corporate claims; class action claims; and general contract, tort, or other claims. The Company may from time to time also be subject to various legal or government claims, disputes, or investigations. Such matters may include, but not be limited to, claims, disputes, allegations, or investigations related to warranty; refund; breach of contract; breach, leak, or misuse of personal data or confidential information; employment; government procurement; intellectual property; government regulation or compliance (including but not limited to anti-corruption requirements, export or other trade controls, data privacy or data protection, cybersecurity requirements, or antitrust/competition law requirements); securities; investor; corporate; or other matters. The Company establishes an accrual for loss contingencies when the loss is both probable and reasonably estimable. On December 14, 2017, members of KT4 Partners LLC (Managing Member Marc Abramowitz) and Sandra Martin Clark, as trustee for the Marc Abramowitz Irrevocable Trust Number 7 (together, “KT4 Plaintiffs”), filed an action in the Delaware Superior Court against the Company and Disruptive Technology Advisers LLC. The complaint alleges tortious interference with prospective economic advantage and civil conspiracy in connection with a potential sale of stock by the KT4 Plaintiffs to a third party. The KT4 Plaintiffs sought compensatory and punitive damages, interest, fees, and costs. On June 27, 2022, the Company and the KT4 Plaintiffs entered into an agreement to settle the litigation and certain other matters. The Company has recorded the amount of the settlement in accrued liabilities and an estimate of the amount to be received from the Company’s insurance in prepaid expenses and other current assets on the condensed consolidated balance sheets as of June 30, 2022. As of June 30, 2022, the Company was not aware of any currently pending legal matters or claims, individually or in the aggregate, that were expected to have a material adverse impact on its condensed consolidated financial statements. Letters of Credit and Guarantees The Company had irrevocable standby letters of credit and guarantees, including bank guarantees, outstanding in the amounts of $56.8 million and $76.2 million as of June 30, 2022 and December 31, 2021, respectively, which were fully collateralized. The Company is required to maintain these letters of credit and guarantees primarily in connection with operating lease agreements, certain customer contracts, and other guarantees and financing arrangements. As of June 30, 2022, these letters of credit and guarantees had expiration dates through August 31, 2031. Warranties and Indemnification The Company generally provides a warranty for its software products and services and a service level agreement (“SLA”) for the Company’s performance of software operations via its operations and maintenance (“O&M”) services to its customers. The Company’s products are generally warranted to perform substantially as described in the associated product documentation during the subscription term or for a period of up to 90 days where the software is hosted by the customer, and the Company includes O&M services as part of its subscription and license agreements to support this warranty and maintain the operability of the software. The Company’s services are generally warranted to be performed in a professional manner and by an adequate staff with knowledge about the products. In the event there is a failure of such warranties, the Company generally is obligated to correct the product or service to conform to the warranty provision, as set forth in the applicable SLA, or, if the Company is unable to do so, the customer is entitled to seek a refund of the purchase price of the product and service (generally prorated over the contract term). Due to the absence of historical warranty claims, the Company’s expectations of future claims related to products under warranty continue to be insignificant. The Company has not recorded warranty expense or related accruals as of June 30, 2022 and December 31, 2021. The Company generally agrees to indemnify its customers against legal claims that the Company’s software products infringe certain third-party intellectual property rights and accounts for its indemnification obligations. In the event of such a claim, the Company is generally obligated to defend its customer against the claim and to either settle the claim at the Company’s expense or pay damages that the customer is legally required to pay to the third-party claimant. In addition, in the event of an infringement, the Company generally agrees to secure the right for the customer to continue using the infringing product; to modify or replace the infringing product; or, if those options are not commercially practicable, to refund the cost of the software, as prorated over the period. To date, the Company has not been required to make any payment resulting from infringement claims asserted against its customers and does not believe that the Company will be liable for such claims in the foreseeable future. As such, the Company has not recorded a liability for infringement costs as of June 30, 2022 and December 31, 2021. The Company has obligations under certain circumstances to indemnify each of the defendant directors and certain officers against judgments, fines, settlements, and expenses related to claims against such directors and certain officers and otherwise to the fullest extent permitted under the law and the Company’s bylaws and Amended and Restated Certificate of Incorporation.

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jun. 30, 2022
Equity [Abstract]
Stockholders' Equity	Stockholders' EquityThe Company’s Class A, Class B, and Class F common stock (collectively, the “common stock”) all have the same rights, except with respect to voting and conversion rights. Class A and Class B common stock have voting rights of 1 and 10 votes per share, respectively. The Class F common stock has the voting rights generally described herein and each share of Class F common stock is convertible at any time, at the option of the holder thereof, into one share of Class B common stock. All shares of Class F common stock are held in a voting trust established by Stephen Cohen, Alexander Karp, and Peter Thiel (the “Founders”). The Class F common stock generally gives the Founders the ability to control up to 49.999999% of the total voting power of the Company's capital stock, so long as the Founders and certain of their affiliates collectively meet a minimum ownership threshold, which was 100.0 million of the Company's equity securities as of June 30, 2022. Holders of the common stock are entitled to dividends when, as, and if declared by the Company’s Board of Directors, subject to the rights of the holders of all classes of stock outstanding having priority rights to dividends. No dividends have been declared as of June 30, 2022. The following represented the total authorized, issued, and outstanding shares for each class of common stock (in thousands): As of June 30, 2022 As of December 31, 2021 Authorized Issued and Outstanding Authorized Issued and Outstanding Class A Common Stock 20,000,000 1,962,382 20,000,000 1,926,589 Class B Common Stock 2,700,000 99,354 2,700,000 99,880 Class F Common Stock 1,005 1,005 1,005 1,005 Total 22,701,005 2,062,741 22,701,005 2,027,474

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation Stock Options The following table summarizes stock option activity for the six months ended June 30, 2022 (in thousands, except per share amounts): Options Outstanding Weighted-Average Exercise Price Per Share Weighted-Average Aggregate Intrinsic Value Balance as of December 31, 2021 349,952 $ 7.81 9.06 $ 3,638,685 Options exercised (11,434) 4.16 — — Options canceled and forfeited (1,942) 4.93 — — Balance as of June 30, 2022 336,576 $ 7.95 8.74 $ 750,129 Options vested and exercisable as of June 30, 2022 175,943 $ 5.46 7.68 $ 676,872 As of June 30, 2022, the total unrecognized stock-based compensation expense related to options outstanding was $799.2 million, which is expected to be recognized over a weighted-average service period of eight years. RSUs The following table summarizes the RSU activity for the six months ended June 30, 2022 (in thousands, except per share amounts): RSUs Outstanding Weighted Average Grant Date Fair Value per Share Balance as of December 31, 2021 153,749 $ 9.56 RSUs granted 11,209 13.96 RSUs vested and converted to shares (23,833) 8.59 RSUs canceled (4,415) 9.07 Balance as of June 30, 2022 136,710 $ 10.11 As of June 30, 2022, the total unrecognized stock-based compensation expense related to the RSUs outstanding was $826.7 million, which the Company expects to recognize over a weighted-average service period of three years. Stock-based Compensation Expense Total stock-based compensation expense was as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Cost of revenue $ 11,211 $ 24,029 $ 22,888 $ 40,006 Sales and marketing 49,405 72,008 98,677 129,294 Research and development 24,978 50,630 51,883 88,504 General and administrative 60,175 86,075 121,644 168,669 Total stock-based compensation expense $ 145,769 $ 232,742 $ 295,092 $ 426,473

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company recorded a provision for income taxes of $2.6 million and a benefit from income taxes of $5.7 million for the three months ended June 30, 2022 and 2021, respectively, and a provision for income taxes of $4.6 million and a benefit from income taxes of $2.6 million for the six months ended June 30, 2022 and 2021, respectively. The Company is subject to income tax in the U.S. as well as other tax jurisdictions in which it conducts business. The Company’s effective tax rate as of June 30, 2022 differs from the U.S. statutory rate primarily due to foreign income taxed at different rates, foreign withholding taxes, and valuation allowances recorded on its losses from the U.S., U.K., and other jurisdictions . The provision for income taxes increased by $8.2 million and $7.2 million for the three and six months ended June 30, 2022, respectively, compared to the same periods in 2021 primarily due to the revaluation of the Company’s United Kingdom (“U.K.”) deferred tax assets as a result of a change in the U.K. corporate tax rate enacted in June 2021. The realization of deferred tax assets is dependent upon the generation of sufficient taxable income of the appropriate character in future periods. The Company assesses its ability to realize the deferred tax assets on a quarterly basis, and it establishes a valuation allowance if it is more likely than not that some portion of the deferred tax assets will not be realized. The Company weighs all available positive and negative evidence, including its earnings history and results of recent operations, scheduled reversals of deferred tax liabilities, projected future taxable income, and tax planning strategies. For example, due to the weight of objectively verifiable negative evidence, including its history of U.S. and U.K. net operating tax losses, the Company believes that it is more likely than not that its U.S. and U.K. deferred tax assets will not be fully realized. Accordingly, the Company has maintained a full valuation allowance on its U.S. and U.K. deferred tax assets as of June 30, 2022. Provisions enacted in the 2017 Tax Cuts and Jobs Act related to the capitalization for tax purposes of research and experimental (“R&E”) expenditures became effective on January 1, 2022. Beginning January 1, 2022, all U.S. and non-U.S. based R&E expenditures must be capitalized and amortized over five and fifteen years, respectively. The U.S. Congress is considering legislation that would defer the amortization requirement to future periods. However, there is no assurance that the provision will be deferred, repealed or otherwise modified. The effect of the requirement did not have a material impact on our income tax provision.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	6 Months Ended
	Jun. 30, 2022
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	Net Loss Per Share Attributable to Common Stockholders The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share amounts): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Numerator Net loss attributable to common stockholders, for diluted net loss per share $ (179,329) $ (138,580) $ (280,708) $ (262,054) Denominator Weighted-average shares used in computing net loss per share, basic 2,054,799 1,894,606 2,045,604 1,858,085 Weighted-average shares used in computing net loss per share, diluted 2,054,799 1,894,606 2,045,604 1,858,085 Net loss per share Net loss per share attributable to common stockholders, basic $ (0.09) $ (0.07) $ (0.14) $ (0.14) Net loss per share attributable to common stockholders, diluted $ (0.09) $ (0.07) $ (0.14) $ (0.14) The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented due to their anti-dilutive effect (in thousands): As of June 30, 2022 2021 Options and stock appreciation rights issued and outstanding 336,576 417,699 RSUs outstanding 134,761 166,722 Warrants to purchase common stock 13,042 13,042 Total 484,379 597,463

Segment and Geographic Informat

Segment and Geographic Information	6 Months Ended
	Jun. 30, 2022
Segment Reporting [Abstract]
Segment and Geographic Information	Segment and Geographic Information The following reporting segment tables reflect the results of the Company’s reportable operating segments consistent with the manner in which the chief operating decision maker (“CODM”) evaluates the performance of each segment and allocates the Company’s resources. The CODM does not evaluate the performance of the Company’s assets on a segment basis for internal management reporting and, therefore, such information is not presented. Contribution is used, in part, to evaluate the performance of, and allocate resources to, each of the segments. A segment’s contribution is calculated as segment revenue less the related costs of revenue and sales and marketing expenses. It excludes certain operating expenses that are not allocated to segments because they are separately managed at the consolidated corporate level. These unallocated costs include stock-based compensation expense, research and development expenses, and general and administrative expenses. Financial information for each reportable segment was as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Revenue: Government $ 262,998 $ 232,119 $ 504,788 $ 440,539 Commercial 210,012 143,523 414,579 276,337 Total revenue $ 473,010 $ 375,642 $ 919,367 $ 716,876 Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Contribution: Government $ 153,642 $ 143,253 $ 293,452 $ 274,999 Commercial 108,885 75,121 221,493 147,664 Total contribution $ 262,527 $ 218,374 $ 514,945 $ 422,663 The reconciliation of contribution to loss from operations is as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Loss from operations $ (41,745) $ (146,148) $ (81,184) $ (260,162) Research and development expenses (1) 63,193 59,894 124,889 120,491 General and administrative expenses (1) 95,310 71,886 176,148 135,861 Total stock-based compensation expense 145,769 232,742 295,092 426,473 Total contribution $ 262,527 $ 218,374 $ 514,945 $ 422,663 ————— (1) Excludes stock-based compensation expense. Geographic Information Revenue by geography is based on the customer’s headquarters or agency location at the time of sale. Revenue is as follows (in thousands, except percentages): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Amount % Amount % Amount % Amount % Revenue: United States $ 290,223 61 % $ 199,930 53 % $ 563,136 61 % $ 398,377 56 % United Kingdom 52,140 11 % 39,935 11 % 102,042 11 % 74,320 10 % Rest of world (1) 130,647 28 % 135,777 36 % 254,189 28 % 244,179 34 % Total revenue $ 473,010 100 % $ 375,642 100 % $ 919,367 100 % $ 716,876 100 % ————— (1) No other country represents 10% or more of total revenue for the three and six months ended June 30, 2022 or 2021.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events On July 1, 2022, the Company entered into an amendment (the “July 2022 Amendment”) to the 2014 Credit Facility, which provided for, among other things, a new incremental delayed draw term loan (“DDTL”) facility in an aggregate principal amount of up to $450.0 million, upon the terms and conditions set forth in the 2014 Credit Facility, as amended, with new and existing lenders. The DDTL facility is available to draw upon through July 1, 2023 and any drawn amounts will mature on March 31, 2027. The DDTL facility, together with the Company’s existing revolving credit facility with an aggregate principal amount of up to $500.0 million, provides for total revolving and DDTL commitments of up to $950.0 million available to draw to fund working capital and general corporate expenditures. No amounts were drawn as of the date of this Quarterly Report on Form 10-Q.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation and Consolidation	Basis of Presentation and Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The accompanying condensed consolidated financial statements include the accounts of Palantir Technologies Inc. and its consolidated subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Investments in entities where the Company holds at least a 20% ownership interest and has the ability to exercise significant influence over the investee, but does not control, are accounted for using the equity method of accounting. Certain prior year balances have been reclassified to conform to the current year presentation. Such reclassifications did not affect total revenues, loss from operations, net loss, or cash flows. The Company's fiscal year ends on December 31. The unaudited condensed consolidated balance sheet as of December 31, 2021 included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including certain notes required by GAAP on an annual reporting basis. In management’s opinion, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the balance sheets and statements of operations, comprehensive loss, stockholders’ equity, and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year or any future period. These unaudited condensed consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements and notes included in its Annual Report on Form 10-K for the year ended December 31, 2021, which was filed with the SEC on February 24, 2022.
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include, but are not limited to, the identification of performance obligations in customer contracts; the valuation of deferred tax assets and uncertain tax positions; the collectability of contract consideration, including accounts receivable; the useful lives of tangible assets; and the incremental borrowing rate for operating leases. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect the Company’s financial position and results of operations.
Cash, Cash Equivalents, and Restricted Cash	Cash, Cash Equivalents, and Restricted Cash The Company considers all highly liquid investments purchased with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents primarily consist of amounts invested in money market funds.
Accounts Receivable and Allowance for Credit Losses	Accounts Receivable and Allowance for Credit Losses Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses, if any. The Company generally grants non-collateralized credit terms to its customers. Allowance for credit losses is based on the Company’s best estimate of probable losses inherent in its accounts receivable portfolio and is determined based on expectations of the customer’s ability to pay by considering factors such as customer type (commercial or government), historical experience, financial position of the customer, age of the accounts receivable, current economic conditions, including the ongoing COVID-19 pandemic, and reasonable and supportable forward-looking factors about its portfolio and future economic conditions. Accounts receivable are written-off and charged against an allowance for credit losses when the Company has exhausted collection efforts without success. Based upon the Company’s assessment as of June 30, 2022 and December 31, 2021, the allowances for credit losses were not material.
Concentrations of Risk	Concentrations of Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, accounts receivable, and marketable securities. Cash equivalents primarily consist of money market funds with original maturities of three months or less, which are invested primarily with U.S. financial institutions. Cash deposits with financial institutions, including restricted cash, generally exceed federally insured limits. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts. The Company is exposed to concentrations of credit risk with respect to accounts receivable presented on the condensed consolidated balance sheets. The Company’s accounts receivable balances as of June 30, 2022 and December 31, 2021 were $265.8 million and $190.9 million, respectively. No single customer represented more than 10% of total accounts receivable as of June 30, 2022 or December 31, 2021.

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Schedule of Cash and Cash Equivalents	The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the amounts shown in the condensed consolidated statements of cash flows (in thousands): As of June 30, 2022 2021 Cash and cash equivalents $ 2,358,393 $ 2,341,156 Restricted cash 28,125 36,750 Restricted cash, noncurrent 28,647 61,914 Total cash, cash equivalents, and restricted cash $ 2,415,165 $ 2,439,820

Investments and Fair Value Me_2

Investments and Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2022
Fair Value Disclosures [Abstract]
Summary Of Assets And Liabilities That Are Measured At Fair Value On A Recurring And Nonrecurring Basis	The following tables present the Company’s assets that are measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation (in thousands): As of June 30, 2022 Total Level 1 Level 2 Level 3 Assets: Cash and cash equivalents: Money market funds $ 385,721 $ 385,721 $ — $ — Certificates of deposit 9,358 — 9,358 — Restricted cash, current and noncurrent Certificates of deposit 32,292 — 32,292 — Marketable securities: Marketable securities 99,210 99,210 — — Total $ 526,581 $ 484,931 $ 41,650 $ — As of December 31, 2021 Total Level 1 Level 2 Level 3 Assets: Cash and cash equivalents: Money market funds $ 507,317 $ 507,317 $ — $ — Certificates of deposit 6,844 — 6,844 — Restricted cash, current and noncurrent Certificates of deposit 45,048 — 45,048 — Marketable securities: Marketable securities 234,153 234,153 — — Total $ 793,362 $ 741,470 $ 51,892 $ —

Balance Sheet Components (Table

Balance Sheet Components (Tables)	6 Months Ended
	Jun. 30, 2022
Balance Sheet Related Disclosures [Abstract]
Schedule of Property and Equipment, Net	Property and equipment, net consisted of the following (in thousands): As of June 30, As of December 31, 2021 Leasehold improvements $ 71,834 $ 72,834 Computer equipment, software, and other 29,467 16,916 Furniture and fixtures 10,137 8,358 Construction in progress 7,591 3,126 Total property and equipment, gross 119,029 101,234 Less: accumulated depreciation and amortization (71,385) (69,930) Total property and equipment, net $ 47,644 $ 31,304
Schedule of Accrued Liabilities	Accrued liabilities consisted of the following (in thousands): As of June 30, As of December 31, 2021 Accrued payroll and related expenses $ 47,046 $ 60,732 Accrued legal 42,912 13,086 Accrued other liabilities 97,610 81,988 Total accrued liabilities $ 187,568 $ 155,806

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	6 Months Ended
	Jun. 30, 2022
Equity [Abstract]
Summary of Total Authorized, Issued, And Outstanding Shares	The following represented the total authorized, issued, and outstanding shares for each class of common stock (in thousands): As of June 30, 2022 As of December 31, 2021 Authorized Issued and Outstanding Authorized Issued and Outstanding Class A Common Stock 20,000,000 1,962,382 20,000,000 1,926,589 Class B Common Stock 2,700,000 99,354 2,700,000 99,880 Class F Common Stock 1,005 1,005 1,005 1,005 Total 22,701,005 2,062,741 22,701,005 2,027,474

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended
	Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]
Summary of Stock Option Activity	The following table summarizes stock option activity for the six months ended June 30, 2022 (in thousands, except per share amounts): Options Outstanding Weighted-Average Exercise Price Per Share Weighted-Average Aggregate Intrinsic Value Balance as of December 31, 2021 349,952 $ 7.81 9.06 $ 3,638,685 Options exercised (11,434) 4.16 — — Options canceled and forfeited (1,942) 4.93 — — Balance as of June 30, 2022 336,576 $ 7.95 8.74 $ 750,129 Options vested and exercisable as of June 30, 2022 175,943 $ 5.46 7.68 $ 676,872
Summary of RSU Activity	The following table summarizes the RSU activity for the six months ended June 30, 2022 (in thousands, except per share amounts): RSUs Outstanding Weighted Average Grant Date Fair Value per Share Balance as of December 31, 2021 153,749 $ 9.56 RSUs granted 11,209 13.96 RSUs vested and converted to shares (23,833) 8.59 RSUs canceled (4,415) 9.07 Balance as of June 30, 2022 136,710 $ 10.11
Summary of Stock-Based Compensation Expense	Total stock-based compensation expense was as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Cost of revenue $ 11,211 $ 24,029 $ 22,888 $ 40,006 Sales and marketing 49,405 72,008 98,677 129,294 Research and development 24,978 50,630 51,883 88,504 General and administrative 60,175 86,075 121,644 168,669 Total stock-based compensation expense $ 145,769 $ 232,742 $ 295,092 $ 426,473

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	6 Months Ended
	Jun. 30, 2022
Earnings Per Share [Abstract]
Summary of Calculation of Basic and Diluted Net Loss Per Share	The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share amounts): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Numerator Net loss attributable to common stockholders, for diluted net loss per share $ (179,329) $ (138,580) $ (280,708) $ (262,054) Denominator Weighted-average shares used in computing net loss per share, basic 2,054,799 1,894,606 2,045,604 1,858,085 Weighted-average shares used in computing net loss per share, diluted 2,054,799 1,894,606 2,045,604 1,858,085 Net loss per share Net loss per share attributable to common stockholders, basic $ (0.09) $ (0.07) $ (0.14) $ (0.14) Net loss per share attributable to common stockholders, diluted $ (0.09) $ (0.07) $ (0.14) $ (0.14)
Summary of Antidilutive Securities	The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented due to their anti-dilutive effect (in thousands): As of June 30, 2022 2021 Options and stock appreciation rights issued and outstanding 336,576 417,699 RSUs outstanding 134,761 166,722 Warrants to purchase common stock 13,042 13,042 Total 484,379 597,463

Segment and Geographic Inform_2

Segment and Geographic Information (Tables)	6 Months Ended
	Jun. 30, 2022
Segment Reporting [Abstract]
Summary of Financial Information for Each Reportable Segment	Financial information for each reportable segment was as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Revenue: Government $ 262,998 $ 232,119 $ 504,788 $ 440,539 Commercial 210,012 143,523 414,579 276,337 Total revenue $ 473,010 $ 375,642 $ 919,367 $ 716,876 Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Contribution: Government $ 153,642 $ 143,253 $ 293,452 $ 274,999 Commercial 108,885 75,121 221,493 147,664 Total contribution $ 262,527 $ 218,374 $ 514,945 $ 422,663
Summary of Reconciliation of Segment Financial Information to Loss from Operations	The reconciliation of contribution to loss from operations is as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Loss from operations $ (41,745) $ (146,148) $ (81,184) $ (260,162) Research and development expenses (1) 63,193 59,894 124,889 120,491 General and administrative expenses (1) 95,310 71,886 176,148 135,861 Total stock-based compensation expense 145,769 232,742 295,092 426,473 Total contribution $ 262,527 $ 218,374 $ 514,945 $ 422,663 ————— (1) Excludes stock-based compensation expense.
Summary of Revenue by Geography	Revenue by geography is based on the customer’s headquarters or agency location at the time of sale. Revenue is as follows (in thousands, except percentages): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Amount % Amount % Amount % Amount % Revenue: United States $ 290,223 61 % $ 199,930 53 % $ 563,136 61 % $ 398,377 56 % United Kingdom 52,140 11 % 39,935 11 % 102,042 11 % 74,320 10 % Rest of world (1) 130,647 28 % 135,777 36 % 254,189 28 % 244,179 34 % Total revenue $ 473,010 100 % $ 375,642 100 % $ 919,367 100 % $ 716,876 100 % ————— (1) No other country represents 10% or more of total revenue for the three and six months ended June 30, 2022 or 2021.

Significant Accounting Polici_4

Significant Accounting Policies - Schedule of Cash and Cash Equivalents (Detail) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021	Jun. 30, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Cash and cash equivalents	$ 2,358,393	$ 2,290,674	$ 2,341,156
Restricted cash	28,125	36,628	36,750
Restricted cash, noncurrent	28,647	39,612	61,914
Total cash, cash equivalents, and restricted cash	$ 2,415,165	$ 2,366,914	$ 2,439,820	$ 2,128,146

Significant Accounting Polici_5

Significant Accounting Policies - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Accounts receivable, net	$ 265,826		$ 265,826		$ 190,923
Revenue Benchmark | Customer Concentration Risk | Customer
Percentage concentration	10%	10%	10%	10%
Accounts Receivable Benchmark | Customer Concentration Risk | Customer
Percentage concentration			10%

Contract Liabilities and Rema_2

Contract Liabilities and Remaining Performance Obligations - Additional information (Detail) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Contract with customer, liability	$ 430		$ 463.3
Revenue recognized from contract liability balances	299.2	$ 285.4
Remaining performance obligation	$ 1,200
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-07-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation (as percent)	44%
Expected timing of satisfaction (in years)	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-07-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation (as percent)	43%
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-07-01 | Minimum
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Expected timing of satisfaction (in years)	13 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-07-01 | Maximum
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Expected timing of satisfaction (in years)	36 months

Investments and Fair Value Me_3

Investments and Fair Value Measurements - Summary Of Assets And Liabilities That Are Measured At Fair Value On A Recurring And Nonrecurring Basis (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Marketable securities:
Total	$ 526,581		$ 526,581		$ 793,362
Revenue	473,010	$ 375,642	919,367	$ 716,876
Money market funds | Cash and cash equivalents:
Cash and cash equivalents:
Cash and cash equivalents	385,721		385,721		507,317
Certificates of deposit | Cash and cash equivalents:
Cash and cash equivalents:
Cash and cash equivalents	9,358		9,358		6,844
Certificates of deposit | Restricted cash, current and noncurrent
Restricted cash, current and noncurrent
Certificates of deposit	32,292		32,292		45,048
Marketable securities | Marketable securities
Marketable securities:
Marketable securities	99,210		99,210		234,153
Level 1
Marketable securities:
Total	484,931		484,931		741,470
Level 1 | Money market funds | Cash and cash equivalents:
Cash and cash equivalents:
Cash and cash equivalents	385,721		385,721		507,317
Level 1 | Certificates of deposit | Cash and cash equivalents:
Cash and cash equivalents:
Cash and cash equivalents	0		0		0
Level 1 | Certificates of deposit | Restricted cash, current and noncurrent
Restricted cash, current and noncurrent
Certificates of deposit	0		0		0
Level 1 | Marketable securities | Marketable securities
Marketable securities:
Marketable securities	99,210		99,210		234,153
Level 2
Marketable securities:
Total	41,650		41,650		51,892
Level 2 | Money market funds | Cash and cash equivalents:
Cash and cash equivalents:
Cash and cash equivalents	0		0		0
Level 2 | Certificates of deposit | Cash and cash equivalents:
Cash and cash equivalents:
Cash and cash equivalents	9,358		9,358		6,844
Level 2 | Certificates of deposit | Restricted cash, current and noncurrent
Restricted cash, current and noncurrent
Certificates of deposit	32,292		32,292		45,048
Level 2 | Marketable securities | Marketable securities
Marketable securities:
Marketable securities	0		0		0
Level 3
Marketable securities:
Total	0		0		0
Level 3 | Money market funds | Cash and cash equivalents:
Cash and cash equivalents:
Cash and cash equivalents	0		0		0
Level 3 | Certificates of deposit | Cash and cash equivalents:
Cash and cash equivalents:
Cash and cash equivalents	0		0		0
Level 3 | Certificates of deposit | Restricted cash, current and noncurrent
Restricted cash, current and noncurrent
Certificates of deposit	0		0		0
Level 3 | Marketable securities | Marketable securities
Marketable securities:
Marketable securities	$ 0		$ 0		$ 0

Investments and Fair Value Me_4

Investments and Fair Value Measurements - Additional Information (Detail) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Dec. 31, 2021 USD ($) oz
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Unrealized gain (loss) for marketable securities	$ (122,800)		$ (174,700)
Realized gain (loss) for marketable securities	(15,700)		(26,600)
Revenue	473,010	$ 375,642	919,367	$ 716,876
Equity securities, fv-ni, cost	89,500		89,500		$ 326,000
Alternative Investment
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in physical commodities					$ 50,900
Investment in number of ounce of gold bars | oz					100
Commercial Contract | Investment Agreement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Maximum contract value	754,900		754,900
Revenue	31,400		70,600
Commercial Contract | Maximum | Investment Agreement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contractual option amounts	$ 116,200		$ 116,200
Subscription contract term			10 years
Commercial Contract | Minimum | Investment Agreement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Subscription contract term			3 years

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Property and Equipment, Net (Detail) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Total property and equipment, gross	$ 119,029	$ 101,234
Less: accumulated depreciation and amortization	(71,385)	(69,930)
Total property and equipment, net	47,644	31,304
Leasehold improvements
Total property and equipment, gross	71,834	72,834
Computer equipment, software, and other
Total property and equipment, gross	29,467	16,916
Furniture and fixtures
Total property and equipment, gross	10,137	8,358
Construction in progress
Total property and equipment, gross	$ 7,591	$ 3,126

Balance Sheet Components - Addi

Balance Sheet Components - Additional information (Detail) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Balance Sheet Related Disclosures [Abstract]
Depreciation and amortization expense excluding the impact of foreign exchange fluctuations	$ 4.5	$ 3.1	$ 8.4	$ 6.3

Balance Sheet Components - Sc_2

Balance Sheet Components - Schedule of Accrued Liabilities (Detail) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Balance Sheet Related Disclosures [Abstract]
Accrued payroll and related expenses	$ 47,046	$ 60,732
Accrued legal	42,912	13,086
Accrued other liabilities	97,610	81,988
Total accrued liabilities	$ 187,568	$ 155,806

Debt (Detail)

Debt (Detail) - Revolving Credit Facility - Line of Credit - USD ($)	3 Months Ended	6 Months Ended
	Mar. 31, 2022	Jun. 30, 2022
2014 Revolving Credit Facility
Short-Term Debt [Line Items]
Debt instrument maximum borrowing capacity	$ 500,000,000	$ 500,000,000
Line of credit facility commitment fee percentage		0.30%
Debt instrument carrying amount		$ 0
Undrawn revolving credit facility amount		500,000,000
Line of credit minimum liquidity to be maintained		$ 50,000,000
2014 Revolving Credit Facility | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Short-Term Debt [Line Items]
Basis spread on variable rate		2%
2014 Revolving Credit Facility | Base Rate
Short-Term Debt [Line Items]
Basis spread on variable rate		1%
March 2022 Amendment
Short-Term Debt [Line Items]
Increase in borrowing capacity	$ 100,000,000

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Millions	1 Months Ended	6 Months Ended
	Dec. 31, 2019	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Loss Contingencies [Line Items]
Letter of credit outstanding amount		$ 56.8		$ 76.2
Investment Commitments | Investment Agreement
Loss Contingencies [Line Items]
Number of shares committed to purchase		3,500,000
Aggregate purchase price commitment		$ 35
Purchase Commitment One
Loss Contingencies [Line Items]
Long-term purchase commitment, amount	$ 1,490
Purchase commitment satisfied		$ 157.3
Purchase commitment for current contract year			$ 167
Period for purchase price commitment (in years)	6 years
Purchase Commitment One | Minimum
Loss Contingencies [Line Items]
Purchase commitment relief amount	$ 30
Period for purchase price commitment (in years)	3 years
Purchase Commitment One | Maximum
Loss Contingencies [Line Items]
Purchase commitment relief amount	$ 50

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Total Authorized, Issued, And Outstanding Shares (Detail) - shares	Jun. 30, 2022	Dec. 31, 2021
Class of Stock [Line Items]
Common stock, shares authorized	22,701,005,000	22,701,005,000
Common stock, shares issued	2,062,741,000	2,027,474,000
Common stock, shares outstanding	2,062,741,000	2,027,474,000
Class A Common Stock
Class of Stock [Line Items]
Common stock, shares authorized	20,000,000,000	20,000,000,000
Common stock, shares issued	1,962,382,000	1,926,589,000
Common stock, shares outstanding	1,962,382,000	1,926,589,000
Class B Common Stock
Class of Stock [Line Items]
Common stock, shares authorized	2,700,000,000	2,700,000,000
Common stock, shares issued	99,354,000	99,880,000
Common stock, shares outstanding	99,354,000	99,880,000
Class F Common Stock
Class of Stock [Line Items]
Common stock, shares authorized	1,005,000	1,005,000
Common stock, shares issued	1,005,000	1,005,000
Common stock, shares outstanding	1,005,000	1,005,000

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Detail) shares in Millions	6 Months Ended
	Jun. 30, 2022 USD ($) vote shares
Minimum ownership threshold (in shares) | shares	100
Dividends declared | $	$ 0
Class F Common Stock
Control of total voting power	50%
Class A Common Stock
Voting rights	1
Class B Common Stock
Voting rights	10

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Detail) $ in Millions	6 Months Ended
	Jun. 30, 2022 USD ($)
Unrecognized share based compensation expense	$ 799.2
Unrecognized share based compensation expense, period for recognition	8 years
Restricted Stock Units (RSUs)
Unrecognized share based compensation expense	$ 826.7
Unrecognized share based compensation expense, period for recognition	3 years

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of Stock Option Activity (Detail) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares
Options Outstanding
Beginning balance (in shares) | shares	349,952,000
Options exercised (in shares) | shares	(11,434,000)
Options canceled and forfeited (in shares) | shares	(1,942,000)
Ending balance (in shares) | shares	336,576,000	349,952,000
Options vested and exercisable (in shares) | shares	175,943,000
Weighted-Average Exercise Price Per Share
Beginning balance (in dollars per share) | $ / shares	$ 7.81
Options exercised (in dollars per share) | $ / shares	4.16
Options canceled and forfeited (in dollars per share) | $ / shares	4.93
Ending balance (in dollars per share) | $ / shares	7.95	$ 7.81
Options vested and exercisable (in dollars per share) | $ / shares	$ 5.46
Weighted-Average Remaining Contractual Life (years) and Aggregate Intrinsic Value
Options outstanding, Weighted-average remaining contractual life (years)	8 years 8 months 26 days	9 years 21 days
Options vested and exercisable (in years)	7 years 8 months 4 days
Options outstanding, aggregate intrinsic value | $	$ 750,129	$ 3,638,685
Options vested and exercisable as of June 30, 2022 | $	$ 676,872

Stock-Based Compensation - Su_2

Stock-Based Compensation - Summary of RSU Activity (Detail) - Restricted Stock Units (RSUs)	6 Months Ended
	Jun. 30, 2022 $ / shares shares
RSUs Outstanding
RSUs unvested and outstanding, beginning balance (in shares) | shares	153,749,000
RSUs granted (in shares) | shares	11,209,000
RSUs vested and converted to shares (in shares) | shares	(23,833,000)
RSUs canceled (in shares) | shares	(4,415,000)
RSUs unvested and outstanding, ending balance (in shares) | shares	136,710,000
Weighted Average Grant Date Fair Value per Share
RSUs unvested and outstanding, beginning balance (in dollars per share) | $ / shares	$ 9.56
RSUs granted (in dollars per share) | $ / shares	13.96
RSUs vested and converted to shares (in dollars per share) | $ / shares	8.59
RSUs cancelled (in dollars per share) | $ / shares	9.07
RSUs unvested and outstanding, ending balance (in dollars per share) | $ / shares	$ 10.11

Stock-Based Compensation - Su_3

Stock-Based Compensation - Summary of Stock Based Compensation Expense (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 145,769	$ 232,742	$ 295,092	$ 426,473
Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	11,211	24,029	22,888	40,006
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	49,405	72,008	98,677	129,294
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	24,978	50,630	51,883	88,504
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 60,175	$ 86,075	$ 121,644	$ 168,669

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Provision for (benefit from) income taxes	$ 2,588	$ (5,661)	$ 4,611	$ (2,559)
Increase (decrease) in income taxes	$ 8,200		$ 7,200

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Summary of Calculation of Basic and Diluted Net Loss Per Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Numerator
Net loss attributable to common stockholders, for diluted net loss per share	$ (179,329)	$ (138,580)	$ (280,708)	$ (262,054)
Denominator
Weighted-average shares used in computing net loss per share, basic	2,054,799,000	1,894,606,000	2,045,604,000	1,858,085,000
Weighted-average shares used in computing net loss per share, diluted	2,054,799,000	1,894,606,000	2,045,604,000	1,858,085,000
Net loss per share
Net loss per share attributable to common stockholders, basic	$ (0.09)	$ (0.07)	$ (0.14)	$ (0.14)
Net loss per share attributable to common stockholders, diluted	$ (0.09)	$ (0.07)	$ (0.14)	$ (0.14)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Summary of Antidilutive Securities (Detail) - shares	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	484,379,000	597,463,000
Options and stock appreciation rights issued and outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	336,576,000	417,699,000
RSUs outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	134,761,000	166,722,000
Warrants to purchase common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	13,042,000	13,042,000

Segment and Geographic Inform_3

Segment and Geographic Information - Summary of Financial Information for Each Reportable Segment (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Segment Reporting Information [Line Items]
Revenue	$ 473,010	$ 375,642	$ 919,367	$ 716,876
Operating Segments
Segment Reporting Information [Line Items]
Revenue	473,010	375,642	919,367	716,876
Contribution	262,527	218,374	514,945	422,663
Operating Segments | Commercial
Segment Reporting Information [Line Items]
Revenue	210,012	143,523	414,579	276,337
Contribution	108,885	75,121	221,493	147,664
Government | Operating Segments
Segment Reporting Information [Line Items]
Revenue	262,998	232,119	504,788	440,539
Contribution	$ 153,642	$ 143,253	$ 293,452	$ 274,999

Segment and Geographic Inform_4

Segment and Geographic Information - Summary of Reconciliation of Segment Financial Information to Loss from Operations (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Segment Reporting Information [Line Items]
Loss from operations	$ (41,745)	$ (146,148)	$ (81,184)	$ (260,162)
Total stock-based compensation expense	145,769	232,742	295,092	426,473
Reconciling items
Segment Reporting Information [Line Items]
Loss from operations	(41,745)	(146,148)	(81,184)	(260,162)
Research and development expenses	63,193	59,894	124,889	120,491
General and administrative expenses	95,310	71,886	176,148	135,861
Total stock-based compensation expense	145,769	232,742	295,092	426,473
Operating Segments
Segment Reporting Information [Line Items]
Total contribution	$ 262,527	$ 218,374	$ 514,945	$ 422,663

Segment and Geographic Inform_5

Segment and Geographic Information - Summary of Revenue by Geography (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 473,010	$ 375,642	$ 919,367	$ 716,876
Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 473,010	$ 375,642	$ 919,367	$ 716,876
Geographic Concentration Risk | Revenue Benchmark
Disaggregation of Revenue [Line Items]
Percentage concentration	100%	100%	100%	100%
Geographic Concentration Risk | Revenue Benchmark | Minimum
Disaggregation of Revenue [Line Items]
Percentage concentration	10%	10%	10%	10%
United States | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 290,223	$ 199,930	$ 563,136	$ 398,377
United States | Geographic Concentration Risk | Revenue Benchmark
Disaggregation of Revenue [Line Items]
Percentage concentration	61%	53%	61%	56%
United Kingdom | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 52,140	$ 39,935	$ 102,042	$ 74,320
United Kingdom | Geographic Concentration Risk | Revenue Benchmark
Disaggregation of Revenue [Line Items]
Percentage concentration	11%	11%	11%	10%
Rest of world | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 130,647	$ 135,777	$ 254,189	$ 244,179
Rest of world | Geographic Concentration Risk | Revenue Benchmark
Disaggregation of Revenue [Line Items]
Percentage concentration	28%	36%	28%	34%

Subsequent Events (Details)

Subsequent Events (Details) - Line of Credit - USD ($) $ in Thousands	Jul. 01, 2022	Jun. 30, 2022	Mar. 31, 2022
2014 Revolving Credit Facility | Subsequent Event [Member]
Subsequent Event [Line Items]
Debt instrument maximum borrowing capacity	$ 950,000
Secured Debt | July 2022 Amendment | Subsequent Event [Member]
Subsequent Event [Line Items]
Debt instrument face amount	$ 450,000
Revolving Credit Facility | 2014 Revolving Credit Facility
Subsequent Event [Line Items]
Debt instrument maximum borrowing capacity		$ 500,000	$ 500,000